Certificates of Analysis
Independent third-party lab results for each batch. Verify any batch at /verify.
10mg — per vial
TRZ010-001CURRENT
View COA ↗
Purity99.789%Net10.59 mgEndotoxins✓ PassProducedMay 2026
30mg — per vial
TRZ030-002CURRENT
View COA ↗
Purity99.82%Net29.98 mgProducedAugust 2026
For full transparency, we also publish batches that did not pass quality testing. These are not sold — click any batch to view its COA.
10mg — per vial
TRZ010-002FAILED
View COA ↗
Reason: Unknown Compound
PurityNetEndotoxins✗ FailProducedMay 2026
30mg — per vial
TRZ030-001FAILED
View COA ↗
Reason: Unknown Compound
Purity0%Net0 mgEndotoxins✗ FailProducedMay 2026

Tirzepatide

Tirzepatide is a synthetic dual-receptor agonist peptide that binds two incretin receptors at once — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both receptors are widely studied in in-vitro metabolic and endocrine research, making this compound a useful reference tool for receptor-signaling studies.

In preclinical laboratory models, tirzepatide has been examined for receptor-binding affinity, downstream cAMP and insulinotropic signaling, and comparative agonist activity. Because it targets both the GIP and GLP-1 pathways simultaneously, it offers a model for characterizing how dual-receptor activation differs from single-receptor approaches.

This vial contains lyophilized Tirzepatide at high purity, verified by independent, third-party analytical testing.

Price range: $85.00 through $130.00

Ships same day M-F (order by 3 PM PT)
Purity guaranteed or replaced
For Research Use Only. Not for human or veterinary use.

Additional information

Purity>99% purity guaranteed
Molecular Weight4813.5 Da
Molecular FormulaC225H348N48O68
SequenceTyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys(C20 fatty diacid)-Gly-Ile-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu
CAS Number2023788-19-2
AppearanceWhite to off-white lyophilized powder
Storage-20°C / -4°F (lyophilized); 4°C / 39°F reconstituted in Bacteriostatic Water, use within 28 days
SolubilitySoluble in water at 1 mg/mL
Size

10mg, 30mg

COA & Testing

Certificates of Analysis
Independent third-party lab results for each batch. Verify any batch at /verify.
10mg — per vial
TRZ010-001CURRENT
View COA ↗
Purity99.789%Net10.59 mgEndotoxins✓ PassProducedMay 2026
30mg — per vial
TRZ030-002CURRENT
View COA ↗
Purity99.82%Net29.98 mgProducedAugust 2026
For full transparency, we also publish batches that did not pass quality testing. These are not sold — click any batch to view its COA.
10mg — per vial
TRZ010-002FAILED
View COA ↗
Reason: Unknown Compound
PurityNetEndotoxins✗ FailProducedMay 2026
30mg — per vial
TRZ030-001FAILED
View COA ↗
Reason: Unknown Compound
Purity0%Net0 mgEndotoxins✗ FailProducedMay 2026

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *

Research Summary: The following information is provided for research context only.

Tirzepatide is a synthetic dual-receptor agonist peptide that binds two incretin receptors at once — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both receptors are widely studied in in-vitro metabolic and endocrine research, making this compound a useful reference tool for receptor-signaling studies.

In preclinical laboratory models, tirzepatide has been examined for receptor-binding affinity, downstream cAMP and insulinotropic signaling, and comparative agonist activity. Because it targets both the GIP and GLP-1 pathways simultaneously, it offers a model for characterizing how dual-receptor activation differs from single-receptor approaches.

This vial contains lyophilized Tirzepatide at high purity, verified by independent, third-party analytical testing.

Added to cart View Cart →